𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson’s Disease

✍ Scribed by Mahyar Etminan PharmD, Ali Samii, Bahi Takkouche, Paula A. Rochon

Book ID
119925265
Publisher
Springer International Publishing AG
Year
2001
Tongue
English
Weight
113 KB
Volume
24
Category
Article
ISSN
0114-5916

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of valvular regurgitation in pa
The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists
✍ Vibeke Guldbrand Rasmussen; Karen Østergaard; Erik Dupont; Steen Hvitfeldt Pouls 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objectives: Several observational studies suggest an association between treatment with ergoline‐derived dopamine agonists and valvular regurgitation. In this article, we present an overview of the literature and conduct a meta‐analysis. ## Methods: Observational studies addressin